Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled magnesium sulfate in COPD exacerbation
IRCT20250528065953N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of magnesium sulfate in chronic obstructive pulmonary disease (COPD), sponsored by Kashan University of Medical Sciences. Started Aug 2025; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20250528065953N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250528065953N1.